<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Data-Review" Owner="NLM">        <PMID Version="1">30327564</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>07</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1532-1827</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>119</Volume>                    <Issue>9</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                    </PubDate>                </JournalIssue>                <Title>British journal of cancer</Title>                <ISOAbbreviation>Br. J. Cancer</ISOAbbreviation>            </Journal>            <ArticleTitle>A prediction model for underestimation of invasive breast cancer after a biopsy diagnosis of ductal carcinoma in situ: based on 2892 biopsies and 589 invasive cancers.</ArticleTitle>            <Pagination>                <MedlinePgn>1155-1162</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41416-018-0276-6</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Patients with a biopsy diagnosis of ductal carcinoma in situ (DCIS) might be diagnosed with invasive breast cancer at excision, a phenomenon known as underestimation. Patients with DCIS are treated based on the risk of underestimation or progression to invasive cancer. The aim of our study was to expand the knowledge on underestimation and to develop a prediction model.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">Population-based data were retrieved from the Dutch Pathology Registry and the Netherlands Cancer Registry for DCIS between January 2011 and June 2012.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 2892 DCIS biopsies, 21% were underestimated invasive breast cancers. In multivariable analysis, risk factors were high-grade DCIS (odds ratio (OR) 1.43, 95% confidence interval (CI): 1.05-1.95), a palpable tumour (OR 2.22, 95% CI: 1.76-2.81), a BI-RADS (Breast Imaging Reporting and Data System) score 5 (OR 2.36, 95% CI: 1.80-3.09) and a suspected invasive component at biopsy (OR 3.84, 95% CI: 2.69-5.46). The predicted risk for underestimation ranged from 9.5 to 80.2%, with a median of 14.7%. Of the 596 invasive cancers, 39% had unfavourable features.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The risk for an underestimated diagnosis of invasive breast cancer after a biopsy diagnosis of DCIS is considerable. With our prediction model, the individual risk of underestimation can be calculated based on routinely available preoperatively known risk factors ( https://www.evidencio.com/models/show/1074 ).</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Meurs</LastName>                    <ForeName>Claudia J C</ForeName>                    <Initials>CJC</Initials>                    <AffiliationInfo>                        <Affiliation>CMAnalyzing, Gounodstraat 16, 6904 HC, Zevenaar, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>van Rosmalen</LastName>                    <ForeName>Joost</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Biostatistics, Erasmus MC, University Medical Center Rotterdam, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Menke-Pluijmers</LastName>                    <ForeName>Marian B E</ForeName>                    <Initials>MBE</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Surgery, Albert Schweitzer Hospital, PO Box 444, 3300 AK, Dordrecht, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ter Braak</LastName>                    <ForeName>Bert P M</ForeName>                    <Initials>BPM</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiology, Albert Schweitzer Hospital, PO Box 444, 3300 AK, Dordrecht, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>de Munck</LastName>                    <ForeName>Linda</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Research, Netherlands Comprehensive Cancer Organisation, PO Box 19079, 3501 DB, Utrecht, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Siesling</LastName>                    <ForeName>Sabine</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Research, Netherlands Comprehensive Cancer Organisation, PO Box 19079, 3501 DB, Utrecht, The Netherlands.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Westenend</LastName>                    <ForeName>Pieter J</ForeName>                    <Initials>PJ</Initials>                    <AffiliationInfo>                        <Affiliation>Laboratory of Pathology Dordrecht, Karel Lotsyweg 145, 3318 AL, Dordrecht, The Netherlands. pwestenend@paldordrecht.nl.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Regional screening organization South West the Netherlands, Maasstadweg 12, 3079 DZ, Rotterdam, The Netherlands. pwestenend@paldordrecht.nl.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>SLP2015-7769</GrantID>                    <Agency>KWF Kankerbestrijding (Dutch Cancer Society)</Agency>                    <Country/>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>10</Month>                <Day>17</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>Br J Cancer</MedlineTA>            <NlmUniqueID>0370635</NlmUniqueID>            <ISSNLinking>0007-0920</ISSNLinking>        </MedlineJournalInfo>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>04</Month>                <Day>06</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>09</Month>                <Day>06</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>09</Month>                <Day>04</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30327564</ArticleId>            <ArticleId IdType="doi">10.1038/s41416-018-0276-6</ArticleId>            <ArticleId IdType="pii">10.1038/s41416-018-0276-6</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>